Cholesterol-Lowering Gene Therapy Shows Early Promise in First Human Trial
New research seems to show the potential of a CRISPR - based gene therapy mean to castrate certain shape of cardiovascular disease . In the world ’s first human trial of the therapy , citizenry given the highest doses experienced significant and long - lasting reductions in their low - compactness lipoprotein cholesterin ( LDL - C ) . The treatment could be used to aid the great unwashed genetically predisposed to high LDL - C and its accompanying health risks ....